Innoviva Stock Forecast for 2023 - 2025 - 2030

Updated on 03/28/2024

Stock Rating
16
Price Target
$15.00
Consensus
Neutral
Upside
1.42%
Analysts
1
Stock Rating
16
Upside
1.42%
Analysts
1
Price Target
$15.00

Innoviva Stock Forecast and Price Target

The average target price for Innoviva's stock set by renowned analysts in recent months is $15.00, representing a potential upside of approximately 1.42% from its last closing price if met by 2025. This estimation is based on a high estimate of $15.00 and a low estimate of $15.00. If you are interested in INVA stock, it is important to also consider its competitors.

$15.00

1.42% Upside

Hold
Hold

Innoviva Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Innoviva's Price has decreased by 100.00%, going from $21.32 to $0.00. In the next year, analysts believe that Fair Value will reach $7.47 – an increase of 100.00%. For the next eight years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
$7.47
2024 Fair Value Forecast
$7.47
2025 Fair Value Forecast
$9.29
2026 Fair Value Forecast
$9.47
2027 Fair Value Forecast
$8.79
2028 Fair Value Forecast
$8.39
2029 Fair Value Forecast
$8.69
2030 Fair Value Forecast
$8.95

Innoviva Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Innoviva's Revenue has decreased by 1.62%, going from $336.79M to $331.34M. 1 analysts predict Innoviva's Revenue will decrease by 3.58% in the next year, reaching $319.47M. For the next nine years, the forecast is for Revenue to grow by 6.98%.

2024 Rev Forecast
$0.32B
2024 Rev Forecast
$0.32B
2025 Rev Forecast
$0.37B
2025 Rev Forecast
$0.37B
2026 Rev Forecast
$0.35B
2027 Rev Forecast
$0.34B
2028 Rev Forecast
$0.35B
2029 Rev Forecast
$0.36B
2030 Rev Forecast
$0.35B

Innoviva Dividend per Share Forecast for 2023 - 2025 - 2030

Innoviva Free Cash Flow Forecast for 2023 - 2025 - 2030

Innoviva EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Innoviva's EBITDA has decreased from $322.84M to $217.98M – a 32.48% drop! The next year, 1 experts forecast that Innoviva's EBITDA will decrease by 45.70%, reaching $118.36M. In 2030, professionals predict that Innoviva's EBITDA will decrease by 34.12%, reaching $143.61M.

2024 EBITDA Forecast
$0.12B
2025 EBITDA Forecast
$0.14B
2026 EBITDA Forecast
$0.13B
2027 EBITDA Forecast
$0.17B
2028 EBITDA Forecast
$0.15B
2029 EBITDA Forecast
$0.15B
2030 EBITDA Forecast
$0.14B

Innoviva EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Innoviva has seen a decline in its EBIT, from $322.82M to $212.30M – a 34.24% decrease. According to the 1 analysts polled, in the next year, Innoviva's EBIT will fall by 53.29%, reaching $99.16M. By 2030, professionals believe that Innoviva's EBIT will have decreased by 46.01%, falling to $114.62M.

2024 EBIT Forecast
$0.10B
2025 EBIT Forecast
$0.12B
2025 EBIT Forecast
$0.12B
2026 EBIT Forecast
$0.11B
2027 EBIT Forecast
$0.11B
2028 EBIT Forecast
$0.11B
2029 EBIT Forecast
$0.11B
2030 EBIT Forecast
$0.11B

Innoviva EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Innoviva's EPS has decreased by 100.00%, going from $2.34 to $0.00. In the next year, analysts believe that EPS will reach $0.82 – an increase of 100.00%. For the next eight years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
$0.82
2024 EPS Forecast
$0.82
2025 EPS Forecast
$1.02
2026 EPS Forecast
$1.04
2027 EPS Forecast
$0.97
2028 EPS Forecast
$0.92
2029 EPS Forecast
$0.95
2030 EPS Forecast
$0.98